Close

Aratana Therapeutics (PETX) Confirms Receipt of Board Nominations from Engaged Capital

April 5, 2018 9:34 AM EDT Send to a Friend
Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative therapeutics for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login